Display Settings:

Format

Send to:

Choose Destination
    Ann N Y Acad Sci. 2003 Nov;1003:292-308.

    Clinical studies implementing glutamate neurotransmission in mood disorders.

    Source

    Department of Psychiatry, Yale University, School of Medicine, New Haven, Connecticut 06519, USA. gerard.sanacora@yale.edu

    Abstract

    Emerging evidence suggests that the amino acid neurotransmitter systems are associated with the pathophysiology and treatment of mood disorders. Recent advances in the areas of molecular neurobiology, pharmacology, and magnetic resonance spectroscopy (MRS) now provide better tools to probe the function of the amino acid neurotransmitter systems and are affording us the opportunity to better investigate the relationship of these systems to mood disorders. Here we review the available literature in the field and suggest a possible pathophysiological model that may account for the many of the findings.

    PMID:
    14684453
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk